Donor Leukocyte Infusion
... Over the past 25 years, bone marrow transplantation has increased cure and long-term survival rates for patients diagnosed with leukemia and other blood disorders. Nonetheless, many patients who succe...

Battling Hodgkin’s Disease: A Difficult Path
... "Every day we are honored to work with brave children who overcome their medical problems by persevering and fighting for their lives," says Tom Rathbone, now retired president of The Clevel...

Childhood Hodgkin''s Disease
... What is Hodgkin''s disease? Hodgkin''s disease is a type of lymphoma. Lymphomas are cancers that develop in the lymph system, part of the body''s immune system. The lymph system is made up of thin tub...

Overview
... Hodgkin''s disease — also known as Hodgkin''s lymphoma — is an uncommon cancer of the lymphatic system, which is part of your immune system. It''s named after the British physician Thomas ...

AIDS-Related Lymphoma Treatment
... Treatment may be one of the following: Standard-dose or low-dose systemic chemotherapy plus intrathecal chemotherapy. A clinical trial of systemic chemotherapy plus colony-stimulating factors and anti...

Adult Hodgkin''s Lymphoma Treatment
... Recurrent adult Hodgkin's lymphoma is cancer that has recurred (come back) after it has been treated. The cancer may come back in the lymph system or in other parts of the body. Treatment of recur...

Hodgkin''s Lymphoma During Pregnancy
... Note: A separate PDQ summary on Adult Hodgkin's Lymphoma Treatment is also available. This summary discusses the treatment of Hodgkin's lymphoma during pregnancy. CallFor more information, U.S...

Childhood Hodgkin''s Lymphoma Treatment
... Primary progressive Hodgkin's lymphoma is lymphoma that continues to grow or spread during treatment. Recurrent Hodgkin's lymphoma is cancer that has recurred (come back) after it has been tre...

Hodgkin''s Lymphoma During Pregnancy
... Note: A separate PDQ summary on Adult Hodgkin's Lymphoma Treatment is also available. Since Hodgkin's lymphoma affects primarily young adults, most oncologists will eventually face the dilemma...